The human insulin-like growth factor 2 (IGF2) mRNA binding proteins 2 (IGF2BP2/IMP2) is
an RNA-binding protein that regulates multiple biological processes. Previously, IGF2BP2 …

RNA‐binding proteins (RBPs) mediate the localization, stability, and translation of the target
transcripts and fine‐tune the physiological functions of the proteins encoded. The insulin …

Abstract Type 2 diabetes (T2D) is the result of interaction between environmental factors and
a strong hereditary component. We review the heritability of T2D as well as the history of …

Type 2 diabetes mellitus (T2DM) is a chronic disease that has reached the levels of a global
epidemic. In order to achieve optimal glucose control, it is often necessary to rely on …

Aging represents the major risk factor for the onset and/or progression of various disorders
including neurodegenerative diseases, metabolic disorders, and bone-related defects. As …

Evidence from observational and in vitro studies suggests that insulin growth-factor-binding
protein type 2 (IGFBP2) is a promising protein in non-communicable diseases, such as …

Context Type 2 diabetes mellitus (T2DM) and cancer share a variety of risk factors and
pathophysiological features. It is becoming increasingly accepted that the 2 diseases are …

Diabetes is a major cause of mortality worldwide. There are several types of diabetes, with
type 2 diabetes mellitus (T2DM) being the most common. Many factors, including …

Insulin-like growth factor 2 mRNA binding protein 2 (IGF2BP2) is a member of the IGF2BP
protein family consisting of IGF2BP1~ 3 with the capacity of binding to many transcripts and …

Nutrigenomics is the study of the gene-nutrient interaction and it indicates that some
nutrients, called bioactive compounds, can mold the genetic expression or change the …